NCT03573362View on ClinicalTrials.gov

Effect of Needle Size in Diagnostic Yield of EBUS-TBNA in Sarcoidosis and Lymphoma

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

January 1, 2025

Study Completion Date

December 31, 2025

Conditions
SarcoidosisLymphomaAdenopathy Hilar
Interventions
DEVICE

ViziShot FLEX 19G needle

EBUS-TBNA using the ViziShot FLEX 19G needle

DEVICE

Vizishot 22G needle (standard)

EBUS-TBNA using the Vizishot 22G needle (standard)

Trial Locations (1)

H2X 3E4

RECRUITING

Centre hospitalier de l'Université de Montréal (CHUM), Montreal

All Listed Sponsors
lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER